What happens when the tools used to fight one of the deadliest cancers fail to tell the full story, and how can a new approach change the game? Glioblastoma, an aggressive brain cancer with a survival rate of less than 15 months for most patients, has long evaded effective treatment, but a
Imagine a world where life-saving medical research grinds to a halt, not because of a lack of expertise or innovation, but due to political disputes far removed from the lab. This scenario is unfolding across the University of California (UC) system, where federal funding freezes initiated by the
Imagine a world where a cancer diagnosis doesn't come with the added burden of financial ruin, where access to life-saving treatment depends not on income or zip code but on need alone, and where policies like Medicaid expansion bring this vision closer to reality. This cornerstone of healthcare
As we delve into the complex world of cancer biology, I’m thrilled to speak with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development. Ivan’s deep knowledge of technology and innovation in the industry offers unique insights into groundbreaking studies,
Introduction Imagine a world where life-saving cancer treatments, once out of reach due to exorbitant costs and lengthy production times, become accessible to patients in desperate need through groundbreaking innovations. CAR-T therapy, a revolutionary immunotherapy that modifies a patient's T
Imagine a world where detecting cancer is as simple as breathing into a device or collecting a urine sample at home, with results available almost instantly through a smartphone app, transforming the way we approach early diagnosis. This vision, once confined to science fiction, is rapidly becoming
